Oruka Therapeutics, Inc. business relationships
Companies named in Oruka Therapeutics, Inc.’s 10-K filed 2026-03-12, and public companies whose annual reports name Oruka Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 2 / 100 Top 5% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Oruka Therapeutics, Inc.’s annual report 1
“into the Cell Line License Agreement (the "Cell Line License Agreement") with WuXi Biologics Ireland Limited ("WuXi” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.